DEA National RX Take Back Day

On Saturday, October 27, 2018, from 10:00am to 2:00pm, the Drug Enforcement Administration (DEA) will hold its 16th National Prescription Drug Take Back Day.  Held on the last Saturday of April and October of every year, this national event addresses a crucial public safety and public health issue.  Since its introduction to the public on September 25, 2010, the DEA has collected and incinerated over 4,982 tons of unwanted, unused, and potentially dangerous medications.

According to the 2016 National Survey on Drug Use and Health 6.2 million Americans misused controlled prescription drugs. Unfortunately, a majority of misused prescription drugs are obtained from family, friends, and relatives from their kitchen, bedroom or medicine cabinet.

The DEA’s National Take Back Day is an opportunity for Americans to help prevent drug addiction and overdose deaths and to raise awareness about the dangers of opioid misuse.

The DEA is asking for your help in getting the word out.  As a DEA-registered  doctor, dentist, nurse practitioner, physician’s assistant, veterinarian and/or state authorized dispensing pharmacist, you are perfectly situated to help DEA spread the word about this important initiative.  You can help by providing patients with information on how to locate a safe, convenient and anonymous collection location on October 27th.

For more information please visit  We have also created a “Partnership Toolbox” where you will find posters and pamphlets, in both English and Spanish, that you can print and place in your waiting rooms.  This site may also be used to identify a collection location in close proximity to your office.

 Please help DEA in its effort to help keep unused prescription drugs out of the wrong hands.  The DEA thanks you for your support!

First Mediterranean Symposium of Comprehensive Joint Care

Dr. Glaser was one of a handful of physicians from the United States to attend THE FIRST MEDITERRANEAN SYMPOSIUM OF COMPREHENSIVE JOINT CARE in Split, Croatia.  It was a remarkable meeting featuring experts in minimally invasive joint treatments. There was an emphasis on regenerative medicine and these presentations were of special interest to dr. Glaser as pain specialists of Greater Chicago incorporate regenerative medicine into their practice.  the Highlight was Saturday morning and dr. Glaser able to spend time in a small group with Dr. Tremolada, the inventor of Lipogems.  This FDA-approved treatment utilizing the natural healing power of adipose tissue will be available soon from the Pain Specialists of Greater Chicago.

Dr. McDaniel & Nevro HF10

Carol, who was diagnosed with degenerative disc disease in 2006, used to have to stay in bed for several days to recuperate any time she was active. Two back surgeries, epidural steroid shots and radio frequency ablations provided some relief from her chronic pain but it was temporary. Carol was forced to take pain medication daily.

When Carol consulted Dr. Scott McDaniel, he recommended HF10 for long-term relief. Carol was reluctant because the over-the-counter external nerve stimulator she tried caused a constant tingling sensation. Dr. McDaniel assured Carol she wouldn’t experience that with HF10. She agreed to a trial that resulted in 75% pain relief.

Following her permanent implant in November 2017, Carol’s back and leg pain, which ranged from 7-8 before the trial, dropped to 2.5 in her back and almost 0 in her legs.

“I am forever grateful for both the pain relief and because now I don’t need pain medication to get through the day,” Carol said. “I have lunch dates with friends, spend time with my grandchildren and even sat through a 3-hour play comfortably – all without having to recuperate for days afterward.”

Learn More ->

#HF10Matters #Nevro #ChronicPain

First Annual Meeting of the Ohio Society of Interventional Pain Physicians

We ​would ​like ​to ​welcome ​you ​to ​an ​exciting ​new ​interventional ​pain ​meeting ​planned ​for ​Ohio ​in ​August ​2017, ​the ​First ​Annual ​Meeting ​of ​the ​Ohio ​Society ​of ​Interventional ​Pain ​Physicians ​(OHSIPP). ​OHSIPP ​has ​been ​in ​existence ​for ​over ​10 ​years ​and ​this ​meeting ​will ​invite ​participation ​from ​all ​the ​six ​academic ​pain ​fellowship ​programs ​in ​Ohio ​plus ​academic ​and ​private ​practice ​physicians ​from ​across ​the ​US. ​We ​hope ​to ​foster ​a ​collegial ​environment ​where ​all ​the ​academic ​pain ​fellowships ​can ​interact ​and ​share ​ideas ​with ​other ​academic ​and ​private ​physicians.

Lecture ​Topics ​Include
Business ​of ​Pain ​Medicine, ​Spinal ​Injections ​and ​Complications, ​Neuromodulation, ​Opioids, ​Advanced ​Techniques, ​Medical ​Marijuana, ​Practice ​Management, ​Regenerative ​Medicine, ​and ​Hands-on ​Ultrasound ​Workshop


Pain Specialists of Greater Chicago Announces Three New Locations

Pain Specialists of Greater Chicago (PSGC), the leading interventional pain management practice, is pleased to announce further expansion of its practice with the addition of a new clinic location and two new procedure locations.

PSGC’s new clinic is located at 1800 McDonough in Hoffman Estates, Ill. The new procedure centers are Ashton Surgical Center, located adjacent to PSGC’s new clinic, and the second procedure center is located at Oak Brook Surgical Center, 2425 W. 22nd St. in Oak Brook, Ill.

“Access to care and patient convenience is paramount in our decision to expand our practice,” noted Scott Glaser, M.D., President of Pain Specialists of Greater Chicago. “This expansion allows us to remain as the leading provider of minimally invasive treatments for pain, and delivering on our promise to provide care and pain relief to patients. Our new locations are both accessible and convenient to the patients who live in the Northwest and Western Suburbs.”

Scott McDaniel, M.D., a fellowship trained interventional pain management specialist, will treat patients and provide care at the new locations. “Dr. McDaniel has exceptional skills in the diagnosis and treatment of pain, and is an asset to our practice,” noted Glaser. “Having Dr. McDaniel on board means that we can treat patients 24-72 hours after receiving a patient phone call or referral. This type of turnaround time is very rare. We believe this makes a dramatic difference and allows us to help individuals with pain more effectively – and now with added locations, we are putting more patients closer to care.”

McDaniel has devoted his time to many national and international organizations, and has presented at numerous national anesthesia and pain medicine conferences. He is particularly interested in multimodal pain management, patient safety, new technologies in neuromodulation, and improving patient access.

“I look forward to consulting and treating patients at our new locations,” noted McDaniel. “We strive to elevate patient care and safety as we eradicate or diminish each individual’s pain as much as possible. I am honored to be a part of a team that continuously provides innovative pain management solutions.”

To learn more about Pain Specialists of Greater Chicago, visit

About Pain Specialists of Greater Chicago

Founded by Scott E. Glaser, M.D., DABIPP and Ira J. Goodman, M.D., Pain Specialists of Greater Chicago has been on the cutting edge of Interventional Pain Management and improving access to care for almost 20 years. The group is dedicated to providing minimally invasive treatments for pain which leads to improved outcomes, reducing disability, reducing narcotic overuse and overdoses, and avoiding invasive surgery.

1 2 3